CORRECTION: EF Hutton Assumed Buy And $14 PT On Hoth
Portfolio Pulse from Benzinga Newsdesk
EF Hutton has assumed a 'Buy' rating and set a $14 price target on Hoth Therapeutics (HOTH).
May 31, 2023 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
EF Hutton's 'Buy' rating and $14 price target on Hoth Therapeutics (HOTH) could positively impact the stock in the short term.
EF Hutton's 'Buy' rating and $14 price target on Hoth Therapeutics (HOTH) indicate a positive outlook for the stock. This news could attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100